deleder2k
Senior Member
- Messages
- 1,130
B-lymphocyte Depletion Using Rituximab in Chronic Fatigue Syndrome/ Myalgic Encephalopathy (CFS/ME). A Randomized Phase-III Study. (RituxME)
Sub study: assessment of Flow-Mediated Dilation and skin microcirculation
study info: http://clinicaltrials.gov/show/NCT02229942
The researchers at Haukeland are doing a sub study along with the Rituximab study which is underway as of now:
Endothelial function: assessment of Flow-Mediated Dilation and skin microcirculation at baseline and repeated during the time interval 17-21 months.
FMD: The researchers want to measure the degree of impaired FMD with respect to the severity of the disease. The patient will be given nitroglycerin to measure change in the FMD.
It should be examined whether FMD changes after Rituximab.
At Haukeland University Hospital they also will conduct an investigation of the microcirculation of the skin on the forearm, using laser measurement.
Anyone tried nitroglycerin here? It widens the blood vessels. I believe the issue is that one develops tolerance rather quickly.
Sub study: assessment of Flow-Mediated Dilation and skin microcirculation
study info: http://clinicaltrials.gov/show/NCT02229942
The researchers at Haukeland are doing a sub study along with the Rituximab study which is underway as of now:
Endothelial function: assessment of Flow-Mediated Dilation and skin microcirculation at baseline and repeated during the time interval 17-21 months.
FMD: The researchers want to measure the degree of impaired FMD with respect to the severity of the disease. The patient will be given nitroglycerin to measure change in the FMD.
It should be examined whether FMD changes after Rituximab.
At Haukeland University Hospital they also will conduct an investigation of the microcirculation of the skin on the forearm, using laser measurement.
Anyone tried nitroglycerin here? It widens the blood vessels. I believe the issue is that one develops tolerance rather quickly.
Last edited: